GHR106 monoclonal antibody (Mab) was generated against the extracellular domain (N1-29) of the GnRH receptor and belongs to a new class of bioequivalent long-acting GnRH analogs. Through various ... both murine…
synthetic peptide corresponding to N1-29 sequence located in the extracellular domain of human GnRH receptor. Among the fourteen established monoclonal antibodies GHR103 and GHR106 were shown to have ... Kdâ??2x10-9 M)…
Gonadotropin-releasing hormone (GnRH) is a neuropeptide hormone responsible for the release of luteinizing hormone (Lh) and follicle-stimulating hormone (Fsh) from the anterior pituitary gland . GnRH have been…
Immunoneutralization of GnRH-I is beneficial to suppress fertility in vivo. To achieve this, we have engineered a plasmid DNA vaccine coding eight repeats of GnRH-I peptide. Here ... males served as untreated control…
Research question: Does the addition of a gonadotrophin-releasing hormone (GnRH) antagonist to cabergoline treatment during the luteal phase in fresh IVF cycles triggered with a GnRH agonist, and planned ... OHSS)?…
Research question: Does the addition of a gonadotrophin-releasing hormone (GnRH) antagonist to cabergoline treatment during the luteal phase in fresh IVF cycles triggered with a GnRH agonist, and planned ... OHSS)?…
large amount of oocyte. The present study aimed to evaluate the role of GnRH agonist on the number and maturation of oocytes and the preimplantation development of embryo ... mouse model of OHSS. Method: Mice were…
Background: The ultrashort flare GnRH agonist/ GnRH antagonist protocol (MDA/Ant) has recently been advocated as a useful option for poor ovarian response (POR). POR patients with repeated IVF failures ... days…
Anti-gonadotropin releasing hormone (GnRH) vaccines may reduce undesirable aggressive behavior of males, while avoiding surgical castration side-effects. The objective of this study was to compare testicle…
Objectives: To examine the influence of type of GnRH-analogue used, on reproductive outcome of elderly patients (> 38 years old) undergoing controlled ovarian hyperstimulation (COH) for IVF. Patients and Methods…
underwent ICSI at Ain Shams university hospital IVF center and other private center using GNRH long antagonist protocol; were randomly divided into two equal groups 1st group 100 cases received
corresponding to N1-29 amino acid residues in the extracellular domains of the human GnRH (Gonadotropin Releasing Hormone) receptor. The humanized form of GHR106 in human IgG4 isoform, GHR106(hIgG4 ... last decade…
pulsatility of GnRH release is essential for reproductive function. The key events in reproductive function, such as puberty onset and ovulatory cycles, are regulated by the frequency and amplitude modulation…
GnRH is the primary and a key hormone which controls the reproductive system in all vertebrates. GnRH binds to its cognate receptor (GnRHR) in pituitary gonadotropes to regulate the synthesis ... Prostate (CaP) is the…
most common endocrine disorders in women of reproductive age. Increased GnRH/luteinizing hormone (LH) pulse frequency is a characteristic of endocrine abnormalities in PCOS. Kisspeptin antagonists reduce LH pulse…
health of a large population of women. The personalized application of Gonadotropin-Releasing Hormone (GnRH) agonists holds significant importance in the treatment of uterine fibroids, as it effectively reduces fibroid…
Anti-gonadotropin releasing hormone (GnRH) vaccines may reduce undesirable aggressive behavior of males, while avoiding surgical castration side-effects. The objective of this study was to compare testicle…
light (650nm, treated n=12) and normal spectrum of light (450nm control=12) on GnRH-I and GnIH mRNA expression, amplitude and frequency of luteinizing hormone (LH) and egg production ... every 3 h for 36h to study the…
generated against the extracellular domain (N1-29 synthetic peptide) of human gonadotropin releasing hormone (GnRH) receptor. It is a first-in-class GnRH analog and can serve as a drug ... humanized (hGHR106) forms were…
Induction of an appropriate immune response against gonadotrophin releasing hormone (GnRH-I) disrupt fertility, reduce fecundity and regress tumours of reproductive system.To disrupt fertility a plasmid DNA vaccine was…
compared the efficacy and safety of GnRH antagonist protocol and GnRH long agonist protocol in patients with PCOS undergoing IVF/ICSI. A total of 100 patients with PCOS candidate ... ovarian hyperstimulation syndrome…
health of a large population of women. The personalized application of Gonadotropin Releasing Hormone (GnRH) agonists holds significant importance in the treatment of uterine fibroids, as it effectively reduces fibroid…
last several years the concept of using a gonadotropin releasing hormone agonist (GnRH-a) for triggering ovulation in patients treated by an antagonist protocol for IVF became almost a routine ... meiosis and cumulus…
450nm control=12) on circulating concentrations of luteinizing hormone (LH), progesterone (P4), estradiol (E2β), GnRH mRNA, pause days and egg production in birds later in the reproductive period from ... study the…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.